Literature DB >> 9315799

The impact of nosocomial infections on patient outcomes following cardiac surgery.

M H Kollef1, L Sharpless, J Vlasnik, C Pasque, D Murphy, V J Fraser.   

Abstract

STUDY
OBJECTIVE: To evaluate the relationship between nosocomial infections and clinical outcomes following cardiac surgery, and to identify risk factors for the development of nosocomial infections in this patient population.
DESIGN: Prospective cohort study.
SETTING: Barnes-Jewish Hospital, St. Louis, a university-affiliated teaching hospital. PATIENTS: Six hundred five consecutive patients undergoing cardiac surgery.
INTERVENTIONS: Prospective patient surveillance and data collection. MAIN OUTCOME MEASURES: Occurrence of nosocomial infections, multiorgan dysfunction, hospital mortality, and risk factors for the acquisition of nosocomial infections.
RESULTS: One hundred thirty-one (21.7%) patients acquired at least one nosocomial infection following cardiac surgery. Four independent risk factors for the development of a nosocomial infection were identified: the duration of mechanical ventilation, postoperative empiric antibiotic administration, the duration of urinary tract catheterization, and female gender. Thirty (5.0%) patients died during their hospitalization. The mortality rate of patients acquiring a nosocomial infection (11.5%) was significantly greater than the mortality rate of patients without a nosocomial infection (3.2%) (odds ratio [OR]=4.0; 95% confidence interval [CI]=2.7 to 5.8; p<0.001). Multiorgan dysfunction was found to be the most important independent determinant of hospital mortality (adjusted OR=23.8; 95% CI=13.5 to 42.1; p<0.001) along with the aortic cross-clamp time (adjusted OR=2.3; 95% CI=1.7 to 3.0; p=0.002) and severity of illness as measured by APACHE II (acute physiology and chronic health evaluation) (adjusted OR=1.1; 95% CI=1.1 to 1.2; p=0.019). Ventilator-associated pneumonia, clinical sepsis, female gender, the cardiopulmonary bypass time, and severity of illness were identified as independent risk factors for the development of multiorgan dysfunction. Among hospital survivors, patients acquiring a nosocomial infection had longer hospital lengths of stay compared to patients without a nosocomial infection (20.1+/-13.0 days vs 9.7+/-4.5 days; p<0.001).
CONCLUSIONS: Nosocomial infections, which are common following cardiac surgery, are associated with prolonged lengths of hospitalization, the development of multiorgan dysfunction, and increased hospital mortality. These data suggest potential interventions for the prevention of nosocomial infections following cardiac surgery that could substantially improve patient outcomes and decrease medical care costs.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9315799     DOI: 10.1378/chest.112.3.666

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  55 in total

1.  Incidence and risk factors for ventilator-associated pneumonia after major heart surgery.

Authors:  Javier Hortal; Maddalena Giannella; Maria Jesús Pérez; José Maria Barrio; Manuel Desco; Emilio Bouza; Patricia Muñoz
Journal:  Intensive Care Med       Date:  2009-06-26       Impact factor: 17.440

Review 2.  Antibiotic stewardship programmes in intensive care units: Why, how, and where are they leading us.

Authors:  Yu-Zhi Zhang; Suveer Singh
Journal:  World J Crit Care Med       Date:  2015-02-04

3.  Pneumonia after cardiac surgery: Experience of the National Institutes of Health/Canadian Institutes of Health Research Cardiothoracic Surgical Trials Network.

Authors:  Gorav Ailawadi; Helena L Chang; Patrick T O'Gara; Karen O'Sullivan; Y Joseph Woo; Joseph J DeRose; Michael K Parides; Vinod H Thourani; Sophie Robichaud; A Marc Gillinov; Wendy C Taddei-Peters; Marissa A Miller; Louis P Perrault; Robert L Smith; Lyn Goldsmith; Keith A Horvath; Kristen Doud; Kim Baio; Annetine C Gelijns; Alan J Moskowitz; Emilia Bagiella; John H Alexander; Alexander Iribarne
Journal:  J Thorac Cardiovasc Surg       Date:  2017-02-09       Impact factor: 5.209

4.  Acinetobacter baumannii ventilator-associated pneumonia: epidemiological and clinical findings.

Authors:  José Garnacho-Montero; C Ortiz-Leyba; Esteban Fernández-Hinojosa; Teresa Aldabó-Pallás; Aurelio Cayuela; Juan A Marquez-Vácaro; Andrés Garcia-Curiel; F J Jiménez-Jiménez
Journal:  Intensive Care Med       Date:  2005-03-23       Impact factor: 17.440

5.  A 15-year study of the changing demographics and infection risk in a new UK cardiac surgery unit.

Authors:  Alice H Taylor; Annelies E Mitchell; Ian M Mitchell
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-06-20

6.  A review of current strategies to reduce intraoperative bacterial contamination of surgical wounds.

Authors:  Pascal M Dohmen; Wolfgang Konertz
Journal:  GMS Krankenhhyg Interdiszip       Date:  2007-12-28

7.  Sex- and diagnosis-dependent differences in mortality and admission cytokine levels among patients admitted for intensive care.

Authors:  Christopher A Guidry; Brian R Swenson; Stephen W Davies; Lesly A Dossett; Kimberley A Popovsky; Hugo Bonatti; Heather L Evans; Rosemarie Metzger; Traci L Hedrick; Carlos A Tache-Léon; Tjasa Hranjec; Irshad H Chaudry; Timothy L Pruett; Addison K May; Robert G Sawyer
Journal:  Crit Care Med       Date:  2014-05       Impact factor: 7.598

8.  Estradiol is associated with mortality in critically ill trauma and surgical patients.

Authors:  Addison K May; Lesly A Dossett; Patrick R Norris; Erik N Hansen; Randalyn C Dorsett; Kimberley A Popovsky; Robert G Sawyer
Journal:  Crit Care Med       Date:  2008-01       Impact factor: 7.598

Review 9.  Application of a complication screening method to congenital heart surgery admissions: a preliminary report.

Authors:  Oscar J Benavidez; Kimberlee Gauvreau; Emile Bacha; Pedro Del Nido; Kathy J Jenkins
Journal:  Pediatr Cardiol       Date:  2007-10-03       Impact factor: 1.655

10.  Prevention of ventilator-associated pneumonia after cardiac surgery: prepare and defend!

Authors:  Patrique Segers; Bas A de Mol
Journal:  Intensive Care Med       Date:  2009-06-26       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.